Beta
Back to UNH.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

UNH Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, UnitedHealth Group's (UNH) operating expenses totaled $15.39B USD, entirely comprising SG&A expenses, as R&D expenses remained at no data across all periods. This latest figure reflects a decline from the Q4'25 peak of $16.99B USD, indicating a moderation in expense growth following a strong upward trajectory in the latter half of FY2025. Over the period from Q2'23 to Q1'26, SG&A expenses exhibited overall stability with moderate fluctuations, starting at $13.81B USD and ranging between $12.49B USD (Q4'24 low) and $16.99B USD (Q4'25 high), driven by a notable 28% year-over-year surge from Q3'24 to Q3'25 before the recent pullback. R&D expenses showed no data throughout, suggesting this category is not applicable or reportable for UNH's operations in a stacked bar chart format. The trend highlights controlled cost management amid seasonal variations, with total operating expenses mirroring SG&A patterns and averaging approximately $14.2B USD quarterly.